Close Menu

NEW YORK – The US Food and Drug Administration announced it has cleared DiaSorin's Liaison XL Zika Capture IgM Assay II for detecting Zika virus IgM antibodies.

DiaSorin's test had previously only been authorized for emergency use by the FDA. As a result of the marketing clearance, the Emergency Use Authorization granted in 2017 has been revoked.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.